Renal cell carcinoma treatment

Renal cell carcinoma, the most common form of kidney cancer, poses particular clinical challenges when it spreads to the lungs, where metastatic deposits can be difficult to detect early and harder still to control. Researchers are working to understand how the molecular and genetic characteristics of individual tumors — including mutations in pathways that regulate cell growth and immune evasion — predict which patients will respond to targeted therapies or immunotherapy. Nephron-sparing surgery has reshaped how localized disease is managed, but determining optimal treatment sequences for metastatic disease, and identifying reliable biomarkers that distinguish responders from non-responders, remain central unresolved problems. Active investigation is focused on combining immunotherapy agents, refining prognostic models, and clarifying how pulmonary involvement affects both staging and therapeutic outcomes.

Works

90,086

Total citations

1,159,792

Keywords

Renal Cell CarcinomaMetastaticTreatmentTherapyPrognostic FactorsMolecular Characterization